Insights Into the Global Alzheimer’s Disease Market, 2023-2032 – Eli Lilly’s Donanemab Poised as Front-Runner for 2024 Market Debut, Set to Rival Biogen and Eisai’s LEQEMBI in Emerging Therapy Arena

Posted on by

DUBLIN, Aug. 18, 2023 /PRNewswire/ — The “Alzheimer’s Disease – Market Insight, Epidemiology And Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Alzheimer’s disease historical and forecasted…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.